Newsroom

August 11, 2025

Amlogenyx Announces Expansion of Board of Directors and Formation of Scientific Advisory Board

Advancing a novel gene therapy to treat Alzheimer’s disease. Appointed three Alzheimer’s experts to newly formed Scientific Advisory Board. Gene therapy expertise enhanced on the board of directors with a new Independent member.

Read more